Cargando…
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity
Autores principales: | Klonoff, David C., Umpierrez, Guillermo E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138381/ https://www.ncbi.nlm.nih.gov/pubmed/32275971 http://dx.doi.org/10.1016/j.metabol.2020.154224 |
Ejemplares similares
-
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
por: Umpierrez, Guillermo E., et al.
Publicado: (2018) -
Diabetic ketoacidosis risk during the COVID-19 pandemic
por: Vellanki, Priyathama, et al.
Publicado: (2021) -
COVID-19: THE NEED FOR INCREASED RECOGNITION OF CUTANEOUS MANIFESTATIONS – LETTER TO THE EDITOR
por: A, Odekunle, et al.
Publicado: (2023) -
Letter to the Editor: Neurohospitalist and COVID-19
por: Duong, Lisa, et al.
Publicado: (2020) -
Letter to the editor: The placenta and COVID-19
por: Al-Lami, Rasha A., et al.
Publicado: (2021)